Drug delivery

Topical Drug Delivery Market Worth $123.2 Billion by 2024 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, August 9, 2019
Pharmacology, Health sciences, Health, Dosage forms, Medical terminology, Ointments, Topical medication, Drug delivery

Homecare setting segment dominated the Topical Drug Delivery Market, by the facility of use, in 2018

Key Points: 
  • Homecare setting segment dominated the Topical Drug Delivery Market, by the facility of use, in 2018
    Homecare settings are the major facility of use of topical formulations.
  • The homecare setting segment accounted for the largest share of the Topical Drug Delivery Market in 2018.
  • In 2018, North America dominated the Topical Drug Delivery Market, followed by Europe.
  • Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM".

Cancer Drug Delivery Markets, 2028

Retrieved on: 
Tuesday, August 6, 2019
Medicine, Health, RTT, Oncology, Cancer treatments, Cancer, Chemotherapy, Drug delivery, War on Cancer, Breast cancer

Drug delivery remains a challenge in the management of cancer.

Key Points: 
  • Drug delivery remains a challenge in the management of cancer.
  • Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery for cancer.
  • Cancer drug delivery is no longer simply wrapping up cancer drugs in a new formulation for different routes of delivery.
  • Cancer gene therapy is a sophisticated form of drug delivery for cancer.

Cancer Drug Delivery Research Report 2019: Focus on Technologies, Markets & Companies - Updated Estimates to 2029 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 6, 2019
Pharmaceutical, Health, Oncology, Branches of biology, Medicine, Oncology, Biology, RTT, Drug delivery, Medical equipment, Chemotherapy, Cancer, Gene therapy, War on Cancer, Cancer biomarker

The "Drug Delivery in Cancer - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Drug Delivery in Cancer - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
  • Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery for cancer.
  • Cancer drug delivery is no longer simply wrapping up cancer drugs in a new formulation for different routes of delivery.
  • Cancer gene therapy is a sophisticated form of drug delivery for cancer.

Transdermal Drug Delivery Markets, 2028

Retrieved on: 
Thursday, August 1, 2019
Pharmacology, Health sciences, Health, Routes of administration, Dosage forms, Transdermal, Drug delivery, Delivery, Pharmacokinetics, Transdermal patches, Route of administration, Ethosome

DUBLIN, Aug. 1, 2019 /PRNewswire/ -- The "Transdermal Drug Delivery - Technologies, Markets, and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Aug. 1, 2019 /PRNewswire/ -- The "Transdermal Drug Delivery - Technologies, Markets, and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
  • This report deals with transdermal drug delivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmucosal routes.
  • Various transdermal drug delivery technologies are described including the use of suitable formulations, carriers and penetration enhancers.
  • The market for transdermal drug delivery is analyzed according to technologies and therapeutic areas from 2018 to 2028.

Transdermal Drug Delivery Research Report 2019: Updated Technologies, Markets, and Companies Analysis & Forecasts 2018-2028 - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 1, 2019
Health, Pharmaceutical, Pharmacology, Health sciences, Health, Routes of administration, Dosage forms, Transdermal, Drug delivery, Delivery, Pharmacokinetics, Transdermal patches, Route of administration, Ethosome

The "Transdermal Drug Delivery - Technologies, Markets, and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Transdermal Drug Delivery - Technologies, Markets, and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
  • This report deals with transdermal drug delivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral, intravascular, subcutaneous and transmucosal routes.
  • Various transdermal drug delivery technologies are described including the use of suitable formulations, carriers and penetration enhancers.
  • The market for transdermal drug delivery is analyzed according to technologies and therapeutic areas from 2018 to 2028.

3-Day Controlled & Modified Drug Release Summit (Philadelphia, United States - August 27-29, 2019) - ResearchAndMarkets.com

Retrieved on: 
Friday, July 26, 2019
Health, Pharmaceutical, Drug delivery, Medical equipment

14+ hours of networking sessions and breaks over two full days to learn from network with pharmaceutical and biotech senior formulation, development and delivery professionals

Key Points: 
  • 14+ hours of networking sessions and breaks over two full days to learn from network with pharmaceutical and biotech senior formulation, development and delivery professionals
    160+ Senior Participants spanning pharma, biotech and specialty delivery & technology companies
    Dynamic Exhibition Hall with multiple leading synthesis, conjugation, formulation development, delivery and modeling experts
    Multiple innovative go-to-market & take-home strategies and learn 2 years of drug delivery strategies and approaches in just 3 days!
  • 2 Events for the Price of One!
  • Co-located and shared exhibition with the 2019 Peptide Drug Design & Delivery Summit
    Pre-Conference Workshop Day - Tuesday, August 27th, 2019
    Main Summit Day One - Wednesday, August 28th, 2019
    KEYNOTE: Precision Medicine & Healthcare Delivery: Making Precision Medicine a Reality via Novel Technology Advancements
    Breakthrough Innovations in the Next Generation of Inhalation Drug Delivery: Alternative Therapeutic Fields for Drug Development
    Nucleic Acid Delivery for Enabling MRNA: Enabling the next Generation of Therapeutics
    Main Summit Day Two - Thursday, August 29th, 2019

The 2019 Peptide Drug Design & Delivery Conference (Philadelphia, United States - August 27-29, 2019) - ResearchAndMarkets.com

Retrieved on: 
Friday, July 26, 2019
Health, Pharmaceutical, Drug delivery, Medical equipment, Life sciences, Biology

14+ hours of networking sessions and breaks over two full days to learn from network with pharmaceutical and biotech senior peptide, formulation, development and delivery professionals

Key Points: 
  • 14+ hours of networking sessions and breaks over two full days to learn from network with pharmaceutical and biotech senior peptide, formulation, development and delivery professionals
    160+ Senior peptide participants spanning pharma, biotech and specialty delivery & technology companies
    Dynamic Exhibition Hall with multiple leading synthesis, conjugation, formulation development, delivery and modeling experts
    Multiple innovative go-to-market & take-home strategies and learn 2 years of drug delivery strategies and approaches in just 3 days!
  • 2 Events for the Price of One!
  • Co-located and shared exhibition with the 2019 Controlled & Modified Drug Release Summit
    Pre-Conference Workshop Day - Tuesday, August 27th, 2019
    Main Summit Day One - Wednesday, August 28th, 2019
    KEYNOTE: Precision Medicine & Healthcare Delivery: Making Precision Medicine a Reality via Novel Technology Advancements
    Breakthrough Innovations in the Next Generation of Inhalation Drug Delivery: Alternative Therapeutic Fields for Drug Development
    Nucleic Acid Delivery for Enabling MRNA: Enabling the next Generation of Therapeutics
    Main Summit Day Two - Thursday, August 29th, 2019

Sorrel Medical Appoints New Chief Commercial Officer to Enable Growth

Retrieved on: 
Tuesday, July 16, 2019
Unilife, Health sciences, Medical equipment, Drug delivery, Drug delivery, Health

NETANYA, Israel, July 16, 2019 /PRNewswire/ -- Sorrel Medical (sorrelmedical.com), a developer and manufacturer of wearable drug delivery devices, announced today the appointment of Michael Ratigan as Chief Commercial Officer.

Key Points: 
  • NETANYA, Israel, July 16, 2019 /PRNewswire/ -- Sorrel Medical (sorrelmedical.com), a developer and manufacturer of wearable drug delivery devices, announced today the appointment of Michael Ratigan as Chief Commercial Officer.
  • Sorrel Medical's award winning wearable drug delivery platform applications have attracted significant customer interest and the need for Sorrel Medical team expansion.
  • Michael will lead the global business development and partnering initiatives, leveraging his 15 years of commercial development experience in the wearable injector drug delivery industry.
  • Prior to Phillips-Medisize, he served as Senior Vice President and Chief Commercial Officer at Unilife Corporation, a provider of injectable drug delivery systems.

Global Transdermal Drug Delivery Market 2019-2023| Availability of Penetration Enhancers to Boost Growth | Technavio

Retrieved on: 
Monday, July 8, 2019
Health, Other Science, Research, General Health, Science, Pharmacology, Health sciences, Health, Routes of administration, Transdermal patch, Microneedle, Transdermal, Route of administration, Transgender hormone therapy, Drug delivery

This global transdermal drug delivery market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.

Key Points: 
  • This global transdermal drug delivery market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.
  • Global transdermal drug delivery market: Availability of penetration enhancers used in transdermal drug delivery
    Researches have been focusing on developing various ways of transferring drugs by modifying the barrier properties of the skin.
  • Apart from the availability of penetration enhancers used in transdermal drug delivery, other factors such as the repurposing of existing drugs, and R&D of microneedle-assisted transdermal drug delivery systems will have a significant impact on the transdermal drug delivery market growth during the forecast period, says a senior analyst at Technavio.
  • Global transdermal drug delivery market: Segmentation analysis
    This market research report segments the global transdermal drug delivery market by application (analgesics, neurological disorders, hormone replacement therapy, cardiovascular disorders, and others), and geographic regions (North America, Europe, Asia, and ROW)
    The North American region led the transdermal drug delivery market in 2018, followed by Europe, Asia, and ROW respectively.

Vaxess Technologies Closes Final Tranche of $8.2 Million Series A and Appoints Dr. Purnanand Sarma to the Board

Retrieved on: 
Thursday, June 27, 2019
Biotechnology, Health, Medical devices, Pharmacology, Health, Vaxess Technologies, Dosage forms, Modified-release dosage, Drug delivery

Vaxess Technologies, a biotechnology company redefining drug delivery with the silk-powered MIMIX smart release patch, today announced it has closed the final tranche of an $8.2 million Series A round.

Key Points: 
  • Vaxess Technologies, a biotechnology company redefining drug delivery with the silk-powered MIMIX smart release patch, today announced it has closed the final tranche of an $8.2 million Series A round.
  • Additionally, Vaxess today announced the appointment of drug delivery and development veteran Dr. Purnanand Sarma to the board of directors.
  • Dr. Sarma brings extensive experience in all aspects of the pharmaceutical business.
  • Formed by founders from Harvard University, the company is developing its proprietary sustained release smart delivery technologies originally developed at Tufts University and MIT.